 | • レポートコード：QY2207C3564 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のてんかん装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にてんかん装置の世界市場のxxx％を占める「ウェアラブル装置」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のてんかん装置の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのてんかん装置市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのてんかん装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 てんかん装置のグローバル主要メーカーには、Boston Scientific Corporation、Koninklijke Philips、Nihon Kohden Corporation、Jude Medical、Compumedics、Natus Medical Incorporated、Medpage、Cerbomed、Liva Nova、MC10、Empatica、Neuropace、Medtronicなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 てんかん装置市場は、種類と用途によって区分されます。世界のてんかん装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ウェアラブル装置、従来型装置、埋め込み型装置 【用途別セグメント】 病院、神経科センター、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - てんかん装置製品概要 - 種類別市場（ウェアラブル装置、従来型装置、埋め込み型装置） - 用途別市場（病院、神経科センター、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のてんかん装置販売量予測2017-2028 - 世界のてんかん装置売上予測2017-2028 - てんかん装置の地域別販売量 - てんかん装置の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別てんかん装置販売量 - 主要メーカー別てんかん装置売上 - 主要メーカー別てんかん装置価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ウェアラブル装置、従来型装置、埋め込み型装置） - てんかん装置の種類別販売量 - てんかん装置の種類別売上 - てんかん装置の種類別価格 ・用途別市場規模（病院、神経科センター、その他） - てんかん装置の用途別販売量 - てんかん装置の用途別売上 - てんかん装置の用途別価格 ・北米市場 - 北米のてんかん装置市場規模（種類別、用途別） - 主要国別のてんかん装置市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのてんかん装置市場規模（種類別、用途別） - 主要国別のてんかん装置市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のてんかん装置市場規模（種類別、用途別） - 主要国別のてんかん装置市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のてんかん装置市場規模（種類別、用途別） - 主要国別のてんかん装置市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのてんかん装置市場規模（種類別、用途別） - 主要国別のてんかん装置市場規模（トルコ、サウジアラビア） ・企業情報 Boston Scientific Corporation、Koninklijke Philips、Nihon Kohden Corporation、Jude Medical、Compumedics、Natus Medical Incorporated、Medpage、Cerbomed、Liva Nova、MC10、Empatica、Neuropace、Medtronic ・産業チェーン及び販売チャネル分析 - てんかん装置の産業チェーン分析 - てんかん装置の原材料 - てんかん装置の生産プロセス - てんかん装置の販売及びマーケティング - てんかん装置の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - てんかん装置の産業動向 - てんかん装置のマーケットドライバー - てんかん装置の課題 - てんかん装置の阻害要因 ・主な調査結果 |
Epilepsy is a sudden and uncontrolled electrical disturbance that affects the brain. It causes changes in the level of feelings, consciousness, or movements, and behavior. Many types of epilepsy are prevalent across the globe based on varying severity. Types of epilepsy are dependent on where and how they begin in the brain. Nearly all epilepsy lasts from 30 seconds to 2 minutes.
Market Analysis and Insights: Global Epilepsy Devices Market
Due to the COVID-19 pandemic, the global Epilepsy Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Wearable Devices accounting for % of the Epilepsy Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Epilepsy Devices market size is valued at US$ million in 2021, while the US and Europe Epilepsy Devices are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Epilepsy Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Epilepsy Devices include Boston Scientific Corporation, Koninklijke Philips, Nihon Kohden Corporation, Jude Medical, Compumedics, Natus Medical Incorporated, Medpage, Cerbomed and Liva Nova, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Epilepsy Devices Scope and Segment
Epilepsy Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Epilepsy Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Wearable Devices
Conventional Devices
Implantable Devices
Segment by Application
Hospitals
Neurology Centers
Others
By Company
Boston Scientific Corporation
Koninklijke Philips
Nihon Kohden Corporation
Jude Medical
Compumedics
Natus Medical Incorporated
Medpage
Cerbomed
Liva Nova
MC10
Empatica
Neuropace
Medtronic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Epilepsy Devices Product Introduction
1.2 Market by Type
1.2.1 Global Epilepsy Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Wearable Devices
1.2.3 Conventional Devices
1.2.4 Implantable Devices
1.3 Market by Application
1.3.1 Global Epilepsy Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Neurology Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Epilepsy Devices Sales Estimates and Forecasts 2017-2028
2.2 Global Epilepsy Devices Revenue Estimates and Forecasts 2017-2028
2.3 Global Epilepsy Devices Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Epilepsy Devices Sales by Region
2.4.1 Global Epilepsy Devices Sales by Region (2017-2022)
2.4.2 Global Sales Epilepsy Devices by Region (2023-2028)
2.5 Global Epilepsy Devices Revenue by Region
2.5.1 Global Epilepsy Devices Revenue by Region (2017-2022)
2.5.2 Global Epilepsy Devices Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Epilepsy Devices Sales by Manufacturers
3.1.1 Global Top Epilepsy Devices Manufacturers by Sales (2017-2022)
3.1.2 Global Epilepsy Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Epilepsy Devices in 2021
3.2 Global Epilepsy Devices Revenue by Manufacturers
3.2.1 Global Epilepsy Devices Revenue by Manufacturers (2017-2022)
3.2.2 Global Epilepsy Devices Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Epilepsy Devices Revenue in 2021
3.3 Global Epilepsy Devices Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Epilepsy Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Epilepsy Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Epilepsy Devices Sales by Type
4.1.1 Global Epilepsy Devices Historical Sales by Type (2017-2022)
4.1.2 Global Epilepsy Devices Forecasted Sales by Type (2023-2028)
4.1.3 Global Epilepsy Devices Sales Market Share by Type (2017-2028)
4.2 Global Epilepsy Devices Revenue by Type
4.2.1 Global Epilepsy Devices Historical Revenue by Type (2017-2022)
4.2.2 Global Epilepsy Devices Forecasted Revenue by Type (2023-2028)
4.2.3 Global Epilepsy Devices Revenue Market Share by Type (2017-2028)
4.3 Global Epilepsy Devices Price by Type
4.3.1 Global Epilepsy Devices Price by Type (2017-2022)
4.3.2 Global Epilepsy Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Epilepsy Devices Sales by Application
5.1.1 Global Epilepsy Devices Historical Sales by Application (2017-2022)
5.1.2 Global Epilepsy Devices Forecasted Sales by Application (2023-2028)
5.1.3 Global Epilepsy Devices Sales Market Share by Application (2017-2028)
5.2 Global Epilepsy Devices Revenue by Application
5.2.1 Global Epilepsy Devices Historical Revenue by Application (2017-2022)
5.2.2 Global Epilepsy Devices Forecasted Revenue by Application (2023-2028)
5.2.3 Global Epilepsy Devices Revenue Market Share by Application (2017-2028)
5.3 Global Epilepsy Devices Price by Application
5.3.1 Global Epilepsy Devices Price by Application (2017-2022)
5.3.2 Global Epilepsy Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Epilepsy Devices Market Size by Type
6.1.1 North America Epilepsy Devices Sales by Type (2017-2028)
6.1.2 North America Epilepsy Devices Revenue by Type (2017-2028)
6.2 North America Epilepsy Devices Market Size by Application
6.2.1 North America Epilepsy Devices Sales by Application (2017-2028)
6.2.2 North America Epilepsy Devices Revenue by Application (2017-2028)
6.3 North America Epilepsy Devices Market Size by Country
6.3.1 North America Epilepsy Devices Sales by Country (2017-2028)
6.3.2 North America Epilepsy Devices Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Epilepsy Devices Market Size by Type
7.1.1 Europe Epilepsy Devices Sales by Type (2017-2028)
7.1.2 Europe Epilepsy Devices Revenue by Type (2017-2028)
7.2 Europe Epilepsy Devices Market Size by Application
7.2.1 Europe Epilepsy Devices Sales by Application (2017-2028)
7.2.2 Europe Epilepsy Devices Revenue by Application (2017-2028)
7.3 Europe Epilepsy Devices Market Size by Country
7.3.1 Europe Epilepsy Devices Sales by Country (2017-2028)
7.3.2 Europe Epilepsy Devices Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Epilepsy Devices Market Size by Type
8.1.1 Asia Pacific Epilepsy Devices Sales by Type (2017-2028)
8.1.2 Asia Pacific Epilepsy Devices Revenue by Type (2017-2028)
8.2 Asia Pacific Epilepsy Devices Market Size by Application
8.2.1 Asia Pacific Epilepsy Devices Sales by Application (2017-2028)
8.2.2 Asia Pacific Epilepsy Devices Revenue by Application (2017-2028)
8.3 Asia Pacific Epilepsy Devices Market Size by Region
8.3.1 Asia Pacific Epilepsy Devices Sales by Region (2017-2028)
8.3.2 Asia Pacific Epilepsy Devices Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Epilepsy Devices Market Size by Type
9.1.1 Latin America Epilepsy Devices Sales by Type (2017-2028)
9.1.2 Latin America Epilepsy Devices Revenue by Type (2017-2028)
9.2 Latin America Epilepsy Devices Market Size by Application
9.2.1 Latin America Epilepsy Devices Sales by Application (2017-2028)
9.2.2 Latin America Epilepsy Devices Revenue by Application (2017-2028)
9.3 Latin America Epilepsy Devices Market Size by Country
9.3.1 Latin America Epilepsy Devices Sales by Country (2017-2028)
9.3.2 Latin America Epilepsy Devices Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Epilepsy Devices Market Size by Type
10.1.1 Middle East and Africa Epilepsy Devices Sales by Type (2017-2028)
10.1.2 Middle East and Africa Epilepsy Devices Revenue by Type (2017-2028)
10.2 Middle East and Africa Epilepsy Devices Market Size by Application
10.2.1 Middle East and Africa Epilepsy Devices Sales by Application (2017-2028)
10.2.2 Middle East and Africa Epilepsy Devices Revenue by Application (2017-2028)
10.3 Middle East and Africa Epilepsy Devices Market Size by Country
10.3.1 Middle East and Africa Epilepsy Devices Sales by Country (2017-2028)
10.3.2 Middle East and Africa Epilepsy Devices Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Corporation Information
11.1.2 Boston Scientific Corporation Overview
11.1.3 Boston Scientific Corporation Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Boston Scientific Corporation Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boston Scientific Corporation Recent Developments
11.2 Koninklijke Philips
11.2.1 Koninklijke Philips Corporation Information
11.2.2 Koninklijke Philips Overview
11.2.3 Koninklijke Philips Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Koninklijke Philips Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Koninklijke Philips Recent Developments
11.3 Nihon Kohden Corporation
11.3.1 Nihon Kohden Corporation Corporation Information
11.3.2 Nihon Kohden Corporation Overview
11.3.3 Nihon Kohden Corporation Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Nihon Kohden Corporation Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nihon Kohden Corporation Recent Developments
11.4 Jude Medical
11.4.1 Jude Medical Corporation Information
11.4.2 Jude Medical Overview
11.4.3 Jude Medical Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Jude Medical Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jude Medical Recent Developments
11.5 Compumedics
11.5.1 Compumedics Corporation Information
11.5.2 Compumedics Overview
11.5.3 Compumedics Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Compumedics Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Compumedics Recent Developments
11.6 Natus Medical Incorporated
11.6.1 Natus Medical Incorporated Corporation Information
11.6.2 Natus Medical Incorporated Overview
11.6.3 Natus Medical Incorporated Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Natus Medical Incorporated Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Natus Medical Incorporated Recent Developments
11.7 Medpage
11.7.1 Medpage Corporation Information
11.7.2 Medpage Overview
11.7.3 Medpage Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Medpage Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medpage Recent Developments
11.8 Cerbomed
11.8.1 Cerbomed Corporation Information
11.8.2 Cerbomed Overview
11.8.3 Cerbomed Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cerbomed Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cerbomed Recent Developments
11.9 Liva Nova
11.9.1 Liva Nova Corporation Information
11.9.2 Liva Nova Overview
11.9.3 Liva Nova Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Liva Nova Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Liva Nova Recent Developments
11.10 MC10
11.10.1 MC10 Corporation Information
11.10.2 MC10 Overview
11.10.3 MC10 Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 MC10 Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 MC10 Recent Developments
11.11 Empatica
11.11.1 Empatica Corporation Information
11.11.2 Empatica Overview
11.11.3 Empatica Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Empatica Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Empatica Recent Developments
11.12 Neuropace
11.12.1 Neuropace Corporation Information
11.12.2 Neuropace Overview
11.12.3 Neuropace Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Neuropace Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Neuropace Recent Developments
11.13 Medtronic
11.13.1 Medtronic Corporation Information
11.13.2 Medtronic Overview
11.13.3 Medtronic Epilepsy Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Medtronic Epilepsy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Medtronic Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Epilepsy Devices Industry Chain Analysis
12.2 Epilepsy Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Epilepsy Devices Production Mode & Process
12.4 Epilepsy Devices Sales and Marketing
12.4.1 Epilepsy Devices Sales Channels
12.4.2 Epilepsy Devices Distributors
12.5 Epilepsy Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Epilepsy Devices Industry Trends
13.2 Epilepsy Devices Market Drivers
13.3 Epilepsy Devices Market Challenges
13.4 Epilepsy Devices Market Restraints
14 Key Findings in The Global Epilepsy Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer